IL-8 silencing by siRNA reduced IL-1β expression in HNSCC cells, suggesting that IL-8 as a main inflammatory mediator improved IL-1β expression in HNSCC. This evidence concerns the gene IL1B and head and neck squamous cell carcinoma.